← Back to screener

Upstream Bio, Inc. UPB

Rank #2127 · Nasdaq · $0.2B market cap
⚠ Going-concern flag — the auditor (PricewaterhouseCoopers LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
32.9
P/E
-3.0
P/B
-1.51
ROE
51.0%
Op. Margin
-3281.2%
Debt Ratio
-10%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -3.0x, P/B -1.51x. Ranks in the top 98% of the universe.

Profitability ★★☆☆☆
Average

ROE 51.0%. Ranks in the top 53% of the universe.

Safety ★★★★★
Excellent

Debt ratio -10%. Ranks in the top 8% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Weak

Revenue decline of 0.4% year over year. Ranks in the top 66% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2024$0.0B$-0.0B$-0.0B$-0.1B-1685.5-9
2025$0.0B$-0.1B$-0.1B$-0.1B-3281.2-10

← See the full screener